Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Health insurance; coverage for non-opioid prescription drugs. Prohibits a health insurance carrier from imposing any cost-sharing, prior authorization, step therapy, or other limitation on coverage of a covered non-opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain that is more restrictive or less favorable to the enrollee relative to a covered opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain.
Introduced
Jan 13, 2026
Last Action
Feb 18, 2026
Session
VA 2026
Sponsors
1 primary · 0 co
Left in Labor and Commerce
Subcommittee recommends laying on the table (5-Y 4-N)
Fiscal Impact Statement from Department of Planning and Budget (HB516)
Assigned HCL sub: Subcommittee #1
Prefiled and ordered printed; Offered 01-14-2026 26101109D
Referred to Committee on Labor and Commerce
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Left in Labor and Commerce